Antitrust Antitrust

Vyera Pharmaceuticals, Martin Shkreli sued by FTC, New York AG for monopolizing market for toxoplasmosis drug

By Joshua Sisco
  • 27 Jan 2020 17:55
  • 27 Jan 2020 17:55
Vyera Pharmaceuticals, a company formerly run by incarcerated hedge fund manager Martin Shkreli, was sued today by the US Federal Trade Commission and the New York Attorney General's Office for monopolizing the market for a toxoplasmosis drug used by patients with HIV and other conditions.

Vyera was formerly Turing Pharmaceuticals, which

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News